Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Company
Chromadex
Chromadex
Activities:
Ingredients
X
LinkedIn
Trending Articles
Rousselot to spotlight holistic benefits of collagen peptides at Vitafoods Europe 2024
The company will highlight three new clinical studies that support new benefits concerning its PEPTAN collagen peptide brand
Tereos unveils new Innovation Centre for European customers
The novel centre brings newly established laboratories for the food, pharmaceutical and cosmetics industries, as well as upgraded analytical technologies
Arla Foods Ingredients new beverage concept for nutrition-conscious gamers
The energy drink contains 15g of protein, taurine, magnesium, zinc, caffeine and vitamins A, B3, B6 and B12
Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight
Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
The role of traceability in the nutraceutical supply chain
The exponential growth of the nutraceutical sector, combined with the unprecedented growth in online marketplaces, makes nutraceuticals highly vulnerable to vast counterfeiting...
Upcoming event
Vitafoods Europe
14–16 May 2024 | Exhibition | Palexpo, Geneva
See all
Related Content
Ingredients
ChromaDex to supply healthy ageing ingredient for H&H Group
H&H Group will be licensed to use Chromadex’s nicotinamide riboside ingredient for products in its Swisse range
Ingredients
ChromaDex R&D facility earns ISO accreditation for ingredient testing
ISO/IEC 17025:2017 accreditation covers testing of the company's Tru Niagen consumer products, its Niagen ingredient, and phytochemical reference standards
Ingredients
Industry-first clinical trial on patent-protected nicotinamide riboside begins
The study will evaluate the impact of ChromaDex Corp's nicotinamide riboside supplementation to help tackle hypertension
Regulatory
ChromaDex receives 2 years market exclusivity for NR chloride ingredient
The nicotinamide riboside chloride ingredient has been approved for use in listed complementary medicines by the Australian Therapeutic Goods Administration
Ingredients
EFSA rules nicotinamide riboside is safe for consumption
The regulatory body has also found evidence to support the substance as a good source of vitamin B3
Research & Development
Animal study confirms that Pterostilbene can help reduce body fat and obesity
Could also reduce the risk of developing other diseases such as obesity
Subscribe now